First of five interviews in a new series with RLAM’s head of multi-asset

Why taking a global approach not only diversifies risk but also allows investors to access a far wider choice of yields.

There’s a time and a place for compromises, your proposition isn’t it.

A Q&A with BB Biotech's Head of Investment Management Daniel Koller reveals how innovation in medicine is offering investment opportunities.

Last of five interviews in new series with RLAM’s head of multi-asset

Fourth of five interviews in new series with RLAM’s head of multi-asset

A due diligence checklist

On-demand version of the webinar available soon

The repercussions from the 2008 Spanish property crash are still being felt by many people, but now there's reason to be much more optimistic.

Architas advent calendar – 23 December